Cyclosporine immunomodulation retards regeneration of surgically transected corneal nerves

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 2, 2012, Pages 732-740

  Namavari, Abed ^a   Chaudhary, Shweta ^a   Chang, Jin Hong ^a   Yco, Lisette ^a   Sonawane, Snehal ^a   Khanolkar, Vishakha ^a   Beatrice, Y Yue ^a   Sarkar, Joy ^a   Jain, Sandeep ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOSPORIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 14; NERVE GROWTH FACTOR; NEUROMODULIN; NEUROTROPHIN 3; NEUROTROPHIN 4; PROTEIN FOS; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA; YELLOW FLUORESCENT PROTEIN; IMMUNOSUPPRESSIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL TEAR; CELL DENSITY; CONTROLLED STUDY; CORNEA STROMA; CORNEA SURGERY; EYE DROPS; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MOUSE; NERVE FIBER GROWTH; NERVE PROJECTION; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TRIGEMINUS GANGLION; ANIMAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORNEA; DRUG EFFECT; INNERVATION; METABOLISM; NEURITE; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REGENERATION;

ANIMALS; CORNEA; CORNEAL STROMA; CYCLOSPORINE; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-6; MICE; NERVE GROWTH FACTORS; NEURITES; REAL-TIME POLYMERASE CHAIN REACTION; REGENERATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859227658     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8445     Document Type: Article

References (55)

1. Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J Anat. 1999;194:1-14.
2. Schmitt AB, Breuer S, Liman J, et al. Identification of regenerationassociated genes after central and peripheral nerve injury in the adult rat. BMC Neurosci. 2003;19:4-8.
3. Dahlin LB. Stimulation of regeneration of the sciatic nerve by experimentally induced inflammation in rat. Scand J Plast Reconstr Surg Hand Surg. 1992;26:121-125.
4. Yong VW. Inflammation in neurological disorders: a help or a hindrance? Neuroscientist. 2010;16:408-420.
5. Popovich PG, Jones TB. Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol Sci. 2003;24:13-17.
6. Schwartz M, Moalem G, Leibowitz-Amit R, Cohen IR. Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci. 1999;22:295-299.
7. Jones TB, Ankeny DP, Guan Z, et al. Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J Neurosci. 2004;24:3752-3761.
8. Hendrix S, Peters EM. Neuronal plasticity and neuroregeneration in the skin: the role of inflammation. J Neuroimmunol. 2007;184: 113-126.
9. Gronert K. Review resolution, the grail for healthy ocular inflammation. Exp Eye Res. 2010;91:478-485.
10. Zhang M, Chen J, Luo L, Xiao Q, Sun M, Liu Z. Altered corneal nerves in aqueous tear deficiency viewed by in vivo confocal microscopy. Cornea. 2005;24:818-824.
11. Benítez-del-Castillo JM, Wasfy MAS, Fernandez C, Garcia-Sanchez J. An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye. Invest Ophthalmol Vis Sci. 2004;45:3030-3035.
12. Benítez-del-Castillo JM, Acosta MC, Wassfi MA, et al. Relation between corneal innervations with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. Invest Ophthalmol Vis Sci. 2007;48:173-181.
13. Villiani E, Galimberti D, Viola F, et al. The cornea in Sjogren's syndrome: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2007;48:2017-2022.
14. Tuisku IS, Konttinen YT, Konttinen LM, et al. Alterations in corneal sensitivity and nerve morphology in patients with primary Sjogren's syndrome. Exp Eye Res. 2008;86:879-885.
15. Tuominen ISJ, Konttinen YT, Vesaluoma MH, Moilanen JAO, Helinto M, Tervo TM. Corneal innervation and morphology in primary Sjogren's syndrome. Invest Ophthalmol Vis Sci. 2003;44: 2545-2549.
16. Li Z, Burns AR, Han L, Rumbaut RE, Smith CW. IL-17 and VEGF are necessary for efficient corneal nerve regeneration. Am J Pathol. 2011;178:1106-1116.
17. Yoshida K, Gage FH. Cooperative regulation of nerve growth factor synthesis and secretion in fibroblast growth factor and other cytokines. Brain Res. 1992;569:14-25.
18. Hattori A, Tanaka E, Murase K, et al. Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in nonneuronal cells. J Biol Chem. 1993;268:2577-2582.
19. Lee HK, Ryu IH, Seo KY, et al. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients. Ophthalmology. 2006;113:198-205.
20. Haeryfar SM, Hoskin DW. Thy-1: more than a mouse pan-T-cell marker. J Immunol. 2004;173:3581-3588.
21. Yu CQ, Rosenblatt MI. Transgenic corneal neurofluorescence in mice: a new model for in vivo investigation of nerve structure and regeneration. Invest Ophthalmol Vis Sci. 2007;48:1535-1542.
22. Al-Aqaba MA, Alomar T, Miri A, Fares U, Otri AM, Dua HS. Ex vivo confocal microscopy of human corneal nerves. Br J Ophthalmol. 2010;94:1251-1257.
23. Beales MP, Funderburgh JL, Jester JV, Hassell JR. Proteoglycan synthesis by bovine keratocytes and corneal fibroblasts: maintenance of the keratocyte phenotype in culture. Invest Ophthalmol Vis Sci. 1999;40:1658-1663.
24. Malin SA, Davis BM, Molliver DC. Production of dissociated sensory neuron cultures and considerations for their use in studying neuronal function and plasticity. Nat Protoc. 2007;2:152-160.
25. Campenot RB, Lund K, Mok SA. Production of compartmented cultures of rat sympathetic neurons. Nat Protoc. 2009;4:1869-1887.
26. Pazyra-Murphy MF, Segal RA. Preparation and maintenance of dorsal root ganglia neurons in compartmented cultures (Online). J Vis Exp. 2008;20:951.
27. Gortzak R, Maftzir G, Aharonov O, Benezra D. Effect of cyclosporine A, rapamycin, and FK-506 on corneal epithelial cells and lymphocyte proliferation. Ocul Immunol Inflamm. 1993;1:203-209.
28. Chen CC, Hsu LW, Huang LT, Huang TL. Chronic administration of cyclosporine A changes expression of BDNF and TrkB in rat hippocampus and midbrain. Neurochem Res. 2010;35:1098-1104.
29. Miyazaki M, Fujikawa Y, Takita C, Tsumura H. Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis. Clin Rheumatol. 2007;26:231-239.
30. Matsuda S, Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology. 2000;47:119-125.
31. Matsuda S, Koyasu S. Regulation of MAPK signaling pathways through immunophilin-ligand complex. Curr Top Med Chem. 2003;3:1358-1367.
32. Su Q, Eugster HP, Ryffel B, Dumont FJ. Cyclosporin A enhances the calcium-dependent induction of AP-1 complex and c-fos mRNA in a T cell lymphoma. Biochem Biophys Res Commun. 1996;229: 249-256.
33. Saggi SJ, Andoh TF, Safirstein R, Bennett WM. Cyclosporin induces renal proto-oncogene RNA message and increased transforming growth factor-beta prior to renal fibrosis: modification by calcium channel blockade in the salt replete rat. Nephrology (Carlton). 2004;9:58-64.
34. Martin RE, Bazan NG. Growth-associated protein Gap43 and nerve cell adhesion molecule in sensory nerves of cornea. Exp Eye Res. 1992;55:307-314.
35. Namavari A, Chaudhary S, Sarkar J, et al. In vivo serial imaging of regenerating corneal nerves after surgical transection in transgenic thy1-YFP mice. Invest Ophthalmol Vis Sci. 2011;52:8025-8032.
36. Brignole F, Pisella PJ, Goldschild M, et al. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci. 2000;41:1356-1363.
37. Stern ME, Gao J, Schwalb TA, et al. Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. Invest Ophthalmol Vis Sci. 2002;43:2609-2614.
38. Pflugfelder SC, Jones D, Ji Z, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999;19:201-211.
39. Solomon A, Dursun D, Liu Z, et al. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283-2292.
40. Smith VA, Rishmawi H, Hussein H, et al. Tear film MMP accumulation and corneal disease. Br J Ophthalmol. 2001;85:147-153.
41. Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren's syndrome. Ophthalmology. 1999;106:811-816.
42. Sall K, Stevenson OD, Mundorf TK, et al. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000;107:631-639.
43. Halloran PF, Kung L, Noujaim J. Calcineurin and the biological effect of cyclosporine and tacrolimus. Transplant Proc. 1998;30: 2167-2170.
44. Banzet S, Koulmann N, Sanchez H, et al. Contraction-induced interleukin-6 transcription in rat slow-type muscle is partly dependent on calcineurin activation. J Cell Physiol. 2007;210:596-601.
45. Banzet S, Koulmann N, Simler N, et al. Fibre-type specificity of interleukin-6 gene transcription during muscle contraction in rat: association with calcineurin activity. J Physiol. 2005;566:839-847.
46. Lara-Ramírez R, Segura-Anaya E, Martínez-Gómez A, Dent MA. Expression of interleukin-6 receptor alpha in normal and injured rat sciatic nerve. Neuroscience. 2008;152:601-608.
47. Galiano M, Liu ZQ, Kalla R, et al. Interleukin-6 (IL6) and cellular response to facial nerve injury: effects on lymphocyte recruitment, early microglial activation and axonal outgrowth in IL6-deficient mice. Eur J Neurosci. 2001;14:327-341.
48. Zhong J, Dietzel ID, Wahle P, Kopf M, Heumann R. Sensory impairments and delayed regeneration of sensory axons in interleukin- 6-deficient mice. J Neurosci. 1999;19:4305-4313.
49. Keller C, Hellsten Y, Steensberg A, Pedersen BK. Differential regulation of IL6 and TNF-α via calcineurin in human skeletal muscle cells. Cytokine. 2006;36:141-147.
50. Foster CS. Immunologic disorders of the conjunctiva, cornea, and sclera. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. 2nd ed. Philadelphia, PA: WB Saunders; 2000: 803-828.
51. Dana MR, Qian Y, Hamrah P. Twenty-five year panorama of corneal immunology. Cornea. 2000;19:625-643.
52. Leibowitz HM, Kupferman A. Antiinflammatory medications. Int Ophthalmol Clin. 1980;20:117-134.
53. Donnenfeld E, Pflugfelder SC. Topical ophthalmic cyclosporine: pharmacology and clinical uses. Surv Ophthalmol. 2009;54:321-338.
54. McDonald JW, Goldberg MP, Gwag BJ, Chi SI, Choi DW. Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures. Ann Neurol. 1996;40:750-758.
55. Pei Y, Sherry DM, McDermott AM. Thy-1 distinguishes human corneal fibroblasts and myofibroblasts from keratocytes. Exp Eye Res. 2004;79:705-712.